{ "company_number": "08064938", "name": "Biopharma Stability Testing Laboratory Limited", "url": "/company/08064938", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2012-05-11", "dissolved_on": null, "sic_codes": [ { "code": "21200", "description": "Manufacture of pharmaceutical preparations", "section": "C", "section_name": "Manufacturing", "url": "/sic/21200" } ], "registered_address": { "id": 1793796, "url": "/address/1793796", "line1": "BIOCITY", "line2": "PENNYFOOT STREET", "post_town": "NOTTINGHAM", "county": "", "country": "", "postcode": "NG1 1GF" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/08064938", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2026-12-28", "last_made_up": "2025-03-28", "category": "TOTAL EXEMPTION FULL", "filings": [ { "url": "/company/08064938/accounts/2025-03-28", "pdf_url": "/company/08064938/accounts/2025-03-28.pdf", "made_up_date": "2025-03-28", "period_start": "2025-03-28", "period_end": "2025-03-28", "entity_name": "Biopharma Stability Testing Laboratory Limited", "dormant": false, "average_employees": "6.00", "tangible_fixed_assets": "36306.00", "debtors": "12215.00", "cash_bank_in_hand": null, "current_assets": "12215.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-262871.00", "total_assets_less_current_liabilities": "-226565.00", "net_assets_liabilities": "-338571.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "2.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2025.zip" }, { "url": "/company/08064938/accounts/2024-03-28", "pdf_url": "/company/08064938/accounts/2024-03-28.pdf", "made_up_date": "2024-03-28", "period_start": "2024-03-28", "period_end": "2024-03-28", "entity_name": "Biopharma Stability Testing Laboratory Limited", "dormant": false, "average_employees": "6.00", "tangible_fixed_assets": "58334.00", "debtors": "157434.00", "cash_bank_in_hand": null, "current_assets": "437434.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "148681.00", "total_assets_less_current_liabilities": "207015.00", "net_assets_liabilities": "107035.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "2.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2024.zip" }, { "url": "/company/08064938/accounts/2023-03-28", "pdf_url": "/company/08064938/accounts/2023-03-28.pdf", "made_up_date": "2023-03-28", "period_start": "2023-03-28", "period_end": "2023-03-28", "entity_name": "Biopharma Stability Testing Laboratory Limited", "dormant": false, "average_employees": "7.00", "tangible_fixed_assets": "95226.00", "debtors": "171856.00", "cash_bank_in_hand": "1.00", "current_assets": "401857.00", "creditors_due_within_one_year": "193288.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "208569.00", "total_assets_less_current_liabilities": "303795.00", "net_assets_liabilities": "142122.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": null, "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2023.zip" }, { "url": "/company/08064938/accounts/2022-03-28", "pdf_url": "/company/08064938/accounts/2022-03-28.pdf", "made_up_date": "2022-03-28", "period_start": "2021-03-29", "period_end": "2022-03-28", "entity_name": "Biopharma Stability Testing Laboratory Limited", "dormant": false, "average_employees": "8.00", "tangible_fixed_assets": "138364.00", "debtors": "357034.00", "cash_bank_in_hand": "131731.00", "current_assets": "506765.00", "creditors_due_within_one_year": "182269.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "324496.00", "total_assets_less_current_liabilities": "462860.00", "net_assets_liabilities": "235488.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "235486.00", "shareholder_funds": "235488.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "187825.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2022.zip" }, { "url": "/company/08064938/accounts/2021-03-28", "pdf_url": "/company/08064938/accounts/2021-03-28.pdf", "made_up_date": "2021-03-28", "period_start": "2020-03-29", "period_end": "2021-03-28", "entity_name": "Biopharma Stability Testing Laboratory Limited", "dormant": false, "average_employees": "9.00", "tangible_fixed_assets": "72471.00", "debtors": "162565.00", "cash_bank_in_hand": "1.00", "current_assets": "384524.00", "creditors_due_within_one_year": "126649.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "257875.00", "total_assets_less_current_liabilities": "330346.00", "net_assets_liabilities": "91663.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": null, "turnover": "309425.00", "other_operating_income": null, "cost_sales": "12020.00", "gross_profit_loss": "297405.00", "administrative_expenses": "431901.00", "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": "-148656.00", "tax_on_profit": "-21107.00", "profit_loss_for_period": "-127549.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2021.zip" }, { "url": "/company/08064938/accounts/2020-03-28", "pdf_url": "/company/08064938/accounts/2020-03-28.pdf", "made_up_date": "2020-03-28", "period_start": "2020-03-28", "period_end": "2020-03-28", "entity_name": "Biopharma Stability Testing Laboratory Limited", "dormant": false, "average_employees": "8.00", "tangible_fixed_assets": "94000.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "351309.00", "creditors_due_within_one_year": "115489.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "240769.00", "total_assets_less_current_liabilities": "334769.00", "net_assets_liabilities": "231212.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "231212.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2020.zip" }, { "url": "/company/08064938/accounts/2019-03-28", "pdf_url": "/company/08064938/accounts/2019-03-28.pdf", "made_up_date": "2019-03-28", "period_start": "2019-03-28", "period_end": "2019-03-28", "entity_name": "Biopharma Stability Testing Laboratory Limited", "dormant": false, "average_employees": "6.00", "tangible_fixed_assets": "18862.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "351465.00", "creditors_due_within_one_year": "165370.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "187095.00", "total_assets_less_current_liabilities": "205957.00", "net_assets_liabilities": "204134.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "204134.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2019.zip" }, { "url": "/company/08064938/accounts/2018-03-28", "pdf_url": "/company/08064938/accounts/2018-03-28.pdf", "made_up_date": "2018-03-28", "period_start": "2018-03-28", "period_end": "2018-03-28", "entity_name": "Biopharma Stability Testing Laboratory Limited", "dormant": false, "average_employees": "7.00", "tangible_fixed_assets": "25387.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "358736.00", "creditors_due_within_one_year": "245476.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "113260.00", "total_assets_less_current_liabilities": "138647.00", "net_assets_liabilities": "135572.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "135572.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2019.zip" }, { "url": "/company/08064938/accounts/2017-03-29", "pdf_url": "/company/08064938/accounts/2017-03-29.pdf", "made_up_date": "2017-03-29", "period_start": "2017-03-29", "period_end": "2017-03-29", "entity_name": "Biopharma Stability Testing Laboratory Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "40694.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "24728.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-188168.00", "total_assets_less_current_liabilities": "-147474.00", "net_assets_liabilities": "-148774.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "-148774.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-March2018.zip" }, { "url": "/company/08064938/accounts/2016-03-30", "pdf_url": "/company/08064938/accounts/2016-03-30.pdf", "made_up_date": "2016-03-30", "period_start": "2016-03-30", "period_end": "2016-03-30", "entity_name": "Biopharma Stability Testing Laboratory Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "60376.00", "debtors": "4963.00", "cash_bank_in_hand": "37714.00", "current_assets": "45177.00", "creditors_due_within_one_year": "187819.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-142642.00", "total_assets_less_current_liabilities": "-82266.00", "net_assets_liabilities": null, "called_up_share_capital": "2.00", "profit_loss_account_reserve": "-82268.00", "shareholder_funds": "-82266.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2016.zip" }, { "url": "/company/08064938/accounts/2015-03-30", "pdf_url": "/company/08064938/accounts/2015-03-30.pdf", "made_up_date": "2015-03-30", "period_start": "2015-03-30", "period_end": "2015-03-30", "entity_name": "Biopharma Stability Testing Laboratory Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "43431.00", "debtors": "35718.00", "cash_bank_in_hand": "11001.00", "current_assets": "49219.00", "creditors_due_within_one_year": "117675.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-68456.00", "total_assets_less_current_liabilities": "-25025.00", "net_assets_liabilities": "-25025.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "-25027.00", "shareholder_funds": "-25025.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-March2016.zip" }, { "url": "/company/08064938/accounts/2014-03-31", "pdf_url": "/company/08064938/accounts/2014-03-31.pdf", "made_up_date": "2014-03-31", "period_start": "2014-03-31", "period_end": "2014-03-31", "entity_name": "Biopharma Stability Testing Laboratory Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "25082.00", "debtors": "33343.00", "cash_bank_in_hand": "7236.00", "current_assets": "40579.00", "creditors_due_within_one_year": "57404.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-16825.00", "total_assets_less_current_liabilities": "8257.00", "net_assets_liabilities": "6443.00", "called_up_share_capital": "1.00", "profit_loss_account_reserve": "6442.00", "shareholder_funds": "6443.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2014.zip" }, { "url": "/company/08064938/accounts/2013-03-31", "pdf_url": "/company/08064938/accounts/2013-03-31.pdf", "made_up_date": "2013-03-31", "period_start": "2013-03-31", "period_end": "2013-03-31", "entity_name": "Biopharma Stability Testing Laboratory Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "23225.00", "debtors": "15353.00", "cash_bank_in_hand": "908.00", "current_assets": "18386.00", "creditors_due_within_one_year": "49504.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-31118.00", "total_assets_less_current_liabilities": "-7893.00", "net_assets_liabilities": null, "called_up_share_capital": "1.00", "profit_loss_account_reserve": "-7894.00", "shareholder_funds": "-7893.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2013.zip" } ], "pdf_only_filings": [], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/08064938/filing-history" }, "confirmation_statement": { "next_due": "2027-05-25", "last_made_up": "2026-05-11" }, "officers": [ { "name": "WILKINSON, Alan Shaun, Dr", "person_url": "/person/6739654", "role": "director", "appointed_on": "2012-05-11", "resigned_on": null, "nationality": "British", "occupation": "", "source": "stream", "retrieved_at": "2026-08-03T14:26:02+00:00" } ], "psc": [ { "name": "Dr Michael Charles Allwood", "kind": "individual-person-with-significant-control", "person_url": "/person/3320268", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent", "voting-rights-25-to-50-percent" ], "notified_on": "2016-04-06", "ceased_on": null, "nationality": "British", "country_of_residence": "England", "source": "snapshot" }, { "name": "Dr Alan Shaun Wilkinson", "kind": "individual-person-with-significant-control", "person_url": "/person/160016", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent", "voting-rights-25-to-50-percent" ], "notified_on": "2016-04-06", "ceased_on": null, "nationality": "British", "country_of_residence": "England", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-08-01", "retrieved_at": "2026-08-14T22:50:00.959197+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }